ANGPTL4 overexpression can induce the GSCs enrichment, which is characterized by the expression of polycomb complex proteins BMI-1 and SOX2, contributing to the resistance of glioma cells to temozolomide [20]. This evidence concerns the gene BMI1 and central nervous system cancer.